Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Bergthaler A, Flatz L, Hegazy AN, Johnson S, Horvath E, Löhning M, Pinschewer DD.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21641-6. doi: 10.1073/pnas.1011998107. Epub 2010 Nov 22.

3.

Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP, de La Torre JC, Oldstone MB.

J Exp Med. 2000 Nov 6;192(9):1249-60.

4.

Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.

Sommerstein R, Ramos da Palma J, Olschläger S, Bergthaler A, Barba L, Lee BP, Pasquato A, Flatz L.

J Virol. 2014 Aug;88(15):8340-8. doi: 10.1128/JVI.00236-14. Epub 2014 May 14.

5.

Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.

Lee MS, Park CH, Jeong YH, Kim YJ, Ha SJ.

PLoS Pathog. 2013;9(7):e1003478. doi: 10.1371/journal.ppat.1003478. Epub 2013 Jul 18.

6.

Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Sullivan BM, Emonet SF, Welch MJ, Lee AM, Campbell KP, de la Torre JC, Oldstone MB.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2969-74. doi: 10.1073/pnas.1019304108. Epub 2011 Jan 26.

8.
9.

CTL escape viral variants. I. Generation and molecular characterization.

Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MB.

Virology. 1995 Jun 20;210(1):29-40.

10.

Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections.

Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ.

J Immunol. 2004 Apr 1;172(7):4204-14.

13.
14.

Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.

Lee AM, Cruite J, Welch MJ, Sullivan B, Oldstone MB.

Virology. 2013 Aug 1;442(2):114-21. doi: 10.1016/j.virol.2013.04.010. Epub 2013 May 16.

15.

Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Mueller SN, Matloubian M, Clemens DM, Sharpe AH, Freeman GJ, Gangappa S, Larsen CP, Ahmed R.

Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15430-5. Epub 2007 Sep 18.

16.

Infection of dendritic cells by lymphocytic choriomeningitis virus.

Sevilla N, Kunz S, McGavern D, Oldstone MB.

Curr Top Microbiol Immunol. 2003;276:125-44. Review.

17.

Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.

Ciurea A, Hunziker L, Zinkernagel RM, Hengartner H.

Immunogenetics. 2001 Apr;53(3):185-9. Review.

PMID:
11398962
18.

Minimal effect of CD103 expression on the control of a chronic antiviral immune response.

Fousteri G, Dave A, Juntti T, Morin B, McClure M, Von Herrath M.

Viral Immunol. 2010 Jun;23(3):285-94. doi: 10.1089/vim.2009.0110.

19.

Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.

Blattman JN, Wherry EJ, Ha SJ, van der Most RG, Ahmed R.

J Virol. 2009 May;83(9):4386-94. doi: 10.1128/JVI.02524-08. Epub 2009 Feb 11.

Supplemental Content

Support Center